MedTrace Logo

Alterations of Immunologic Mediators During Severe Sepsis

NCT00484146 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-02-09

No results posted yet for this study

Summary

Severe sepsis induces significant changes in expression of insulin- and toll-like receptors, cytokines, markers of apoptosis, and activation of t- and b-lymphocytes.

Conditions

  • Severe Sepsis

Sponsors & Collaborators

  • University of Halle Medical Faculty

    collaborator OTHER

  • Klinikum St. Georg gGmbH

    lead OTHER

Principal Investigators

  • Armin R Sablotzki, MD · Klinikum St. Georg gGmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00484146 on ClinicalTrials.gov